These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34354352)

  • 21. Erratum: Doxorubicin-Loaded Poly (Lactic-Co-Glycolic Acid) Nanoparticles Coated with Chitosan/Alginate by Layer by Layer Technology for Antitumor Applications [Corrigendum].
    Int J Nanomedicine; 2021; 16():4187. PubMed ID: 34177263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erratum: In vitro Anticancer Effects of
    Int J Nanomedicine; 2021; 16():6263-6264. PubMed ID: 34548790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erratum: Novel Aptamer-Functionalized Nanoparticles Enhances Bone Defect Repair by Improving Stem Cell Recruitment [Corrigendum].
    Int J Nanomedicine; 2020; 15():6093-6094. PubMed ID: 32982214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erratum: Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process [Corrigendum].
    Int J Nanomedicine; 2019; 14():6733-6734. PubMed ID: 31507317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erratum: Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum].
    Int J Nanomedicine; 2019; 14():6867. PubMed ID: 31509111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erratum: Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex [Corrigendum].
    Int J Nanomedicine; 2019; 14():6587-6588. PubMed ID: 32461716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erratum: A Reliable Approach for Assessing Size-Dependent Effects of Silica Nanoparticles on Cellular Internalization Behavior and Cytotoxic Mechanisms [Corrigendum].
    Int J Nanomedicine; 2020; 15():10169. PubMed ID: 33363372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erratum: Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum].
    Int J Nanomedicine; 2021; 16():7495-7496. PubMed ID: 34785896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erratum: Radiolabeling and Preliminary Evaluation of
    Int J Nanomedicine; 2022; 17():1479-1480. PubMed ID: 35378881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erratum: Silver Nanoparticles as Chlorhexidine and Metronidazole Drug Delivery Platforms: Their Potential Use in Treating Periodontitis [Corrigendum].
    Int J Nanomedicine; 2023; 18():1613-1614. PubMed ID: 37020687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erratum: Emodin-Conjugated PEGylation of Fe
    Int J Nanomedicine; 2022; 17():711-712. PubMed ID: 35210770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erratum: Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum].
    Int J Nanomedicine; 2022; 17():5047-5048. PubMed ID: 36303805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erratum: Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature [Corrigendum].
    Int J Nanomedicine; 2022; 17():183-184. PubMed ID: 35046653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erratum: Anti-Inflammatory Effects of Magnetically Targeted Mesenchymal Stem Cells on Laser-Induced Skin Injuries in Rats [Corrigendum].
    Int J Nanomedicine; 2020; 15():6735-6736. PubMed ID: 33061356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erratum: Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum].
    Int J Nanomedicine; 2021; 16():1927. PubMed ID: 33707947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erratum: Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells [Corrigendum].
    Int J Nanomedicine; 2023; 18():659-662. PubMed ID: 36798533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erratum: A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum].
    Int J Nanomedicine; 2020; 15():6067. PubMed ID: 32884262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erratum: Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum].
    Int J Nanomedicine; 2021; 16():237-238. PubMed ID: 33469283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erratum: Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum].
    Int J Nanomedicine; 2020; 15():839. PubMed ID: 32103940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erratum: Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway [Corrigendum].
    Int J Nanomedicine; 2021; 16():6531-6533. PubMed ID: 34602815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.